Literature DB >> 11587456

The importance of the maximum pulmonary artery regurgitant velocity following repair of tetralogy of Fallot: a pilot study.

S B Greenberg1, E Eshaghpour.   

Abstract

BACKGROUND: Tetralogy of Fallot repairs invariably result in pulmonary regurgitation with the long term sequelae of ventricular dilatation and dysfunction.
OBJECTIVE: The purpose of this study is to correlate pulmonary flow parameters with right ventricular size and function.
MATERIALS AND METHODS: Pulmonary artery velocity was mapped by magnetic resonance flow analysis in seven children with pulmonary regurgitation following tetralogy of Fallot repair. Right and left ventricular volumes were determined by Simpson's rule from double oblique cine gradient echo images of the heart. The ejection fraction was calculated for each ventricle. Right ventricular enlargement was normalized for patient size by calculating the ratios of right ventricle end diastolic and end systolic volumes to the left ventricle end diastolic and end systolic volumes respectively (EDV RV:LV and ESV RV:LV). The maximum pulmonary artery antegrade and retrograde velocities and the ratio of the time for antegrade to regurgitant flow were compared to ventricular function and volume measurements by regression analysis.
RESULTS: A significant linear relationship between the maximum regurgitant pulmonary artery velocity and EDV RV:LV was identified (r2 = 0.82).
CONCLUSION: An elevated maximum pulmonary regurgitant velocity correlated well with the degree of right ventricular enlargement in patients following tetralogy of Fallot repair. If the results are verified by a larger study, the maximum pulmonary regurgitant velocity may be substituted for the more cumbersome direct measurement of right ventricular size.

Entities:  

Mesh:

Year:  2001        PMID: 11587456     DOI: 10.1023/a:1010664925818

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  5 in total

Review 1.  Ventricular function.

Authors:  S B Greenberg; S K Sandhu
Journal:  Radiol Clin North Am       Date:  1999-03       Impact factor: 2.303

2.  Optimal imaging in assessment of right ventricular function in tetralogy of Fallot with pulmonary regurgitation.

Authors:  W A Helbing; A de Roos
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

3.  Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot.

Authors:  R A Niezen; W A Helbing; E E van der Wall; R J van der Geest; S A Rebergen; A de Roos
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

4.  Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping.

Authors:  S A Rebergen; J G Chin; J Ottenkamp; E E van der Wall; A de Roos
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

5.  Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy.

Authors:  G K Singh; S B Greenberg; Y S Yap; D P Delany; B R Keeton; J L Monro
Journal:  Am J Cardiol       Date:  1998-06-01       Impact factor: 2.778

  5 in total
  3 in total

1.  Visualization of aorto pulmonary connections in tetralogy of Fallot.

Authors:  T Oosterhof; B J M Mulder
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

2.  Diastolic dysfunction: a new additional criterion for optimal timing of pulmonary valve replacement in adult patient with tetralogy of Fallot?

Authors:  Barbara J M Mulder; Hubert W Vliegen; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

3.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.